Literature DB >> 15016698

British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary.

Bryan Williams1, Neil R Poulter, Morris J Brown, Mark Davis, Gordon T McInnes, John F Potter, Peter S Sever, Simon McG Thom.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15016698      PMCID: PMC381142          DOI: 10.1136/bmj.328.7440.634

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  22 in total

1.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  North of England evidence based guidelines development project: methods of developing guidelines for efficient drug use in primary care.

Authors:  M Eccles; N Freemantle; J Mason
Journal:  BMJ       Date:  1998-04-18

4.  Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.

Authors:  B Neal; S MacMahon; N Chapman
Journal:  Lancet       Date:  2000-12-09       Impact factor: 79.321

5.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group.

Authors:  F M Sacks; L P Svetkey; W M Vollmer; L J Appel; G A Bray; D Harsha; E Obarzanek; P R Conlin; E R Miller; D G Simons-Morton; N Karanja; P H Lin
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

6.  Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension.

Authors:  J He; P K Whelton; L J Appel; J Charleston; M J Klag
Journal:  Hypertension       Date:  2000-02       Impact factor: 10.190

7.  Optimisation of antihypertensive treatment by crossover rotation of four major classes.

Authors:  J E Dickerson; A D Hingorani; M J Ashby; C R Palmer; M J Brown
Journal:  Lancet       Date:  1999-06-12       Impact factor: 79.321

Review 8.  Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.

Authors:  L Ramsay; B Williams; G Johnston; G MacGregor; L Poston; J Potter; N Poulter; G Russell
Journal:  J Hum Hypertens       Date:  1999-09       Impact factor: 3.012

9.  Department of veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

Authors:  B J Materson; D J Reda; W C Cushman
Journal:  Am J Hypertens       Date:  1995-02       Impact factor: 2.689

10.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

View more
  194 in total

1.  Guidelines from the British Hypertension Society: numbers are missing.

Authors:  Peter Davies
Journal:  BMJ       Date:  2004-09-04

2.  Guidelines from the British Hypertension Society: BHS is set to bankrupt NHS.

Authors:  Martin G Duerden
Journal:  BMJ       Date:  2004-09-04

3.  Guidelines from the British Hypertension Society: cholesterol values seem to diverge.

Authors:  Gerry E Burns
Journal:  BMJ       Date:  2004-09-04

4.  Treating hypertension with guidelines in general practice.

Authors:  Neil C Campbell; Peter Murchie
Journal:  BMJ       Date:  2004-09-04

5.  Guidelines from the British Hypertension Society: life in the real world may not allow recommendations to be implemented.

Authors:  Paul N Green
Journal:  BMJ       Date:  2004-09-04

6.  Guidelines from the British Hypertension Society.

Authors:  Stéphane Laurent
Journal:  BMJ       Date:  2004-03-13

7.  The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease.

Authors:  Nicola C Edwards; Richard P Steeds; Colin D Chue; Paul M Stewart; Charles J Ferro; Jonathan N Townend
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

8.  Effect of general practitioner education on adherence to antihypertensive drugs: cluster randomised controlled trial.

Authors:  Nudrat Noor Qureshi; Juanita Hatcher; Nish Chaturvedi; Tazeen H Jafar
Journal:  BMJ       Date:  2007-11-08

Review 9.  Drug Treatment of Hypertension: Focus on Vascular Health.

Authors:  Alan C Cameron; Ninian N Lang; Rhian M Touyz
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

10.  Knowledge of blood pressure in a U.K. general public population.

Authors:  J Slark; M S Khan; P Bentley; P Sharma
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.